Stay updated on Effect of Oral AT1001 in Fabry Disease Clinical Trial

Sign up to get notified when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Effect of Oral AT1001 in Fabry Disease Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page shows a version update from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-28T03:12:09.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The Publications section wording was updated to indicate that PubMed publications are automatically filled and may not all be about the study, and the revision label was updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-21T02:05:21.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The banner about government funding and operating status was removed from the page.
    Difference
    0.3%
    Check dated 2025-11-13T22:40:01.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Minor layout and formatting tweaks observed on the page; core study details, locations, eligibility criteria, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-30T13:18:54.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added a government operations notice and new version v3.2.0; removed older MedlinePlus topics and Revision: v3.0.2. Overall, minimal impact beyond operational status and version update.
    Difference
    3%
    Check dated 2025-10-02T01:20:37.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Updated page revision to v3.1.0 and removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with Revision: v3.0.2.
    Difference
    0.5%
    Check dated 2025-09-30T11:49:07.000Z thumbnail image

Stay in the know with updates to Effect of Oral AT1001 in Fabry Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.